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Pheno-, genotypic and toxin gene analysis has not been done yet all in one for Nigerian 
Staphylococcus aureus population. This study provides a comprehensive overview on the 
molecular epidemiology and genetic diversity of S. aureus at the largest university clinic in 
Ibadan, Nigeria. At the University Teaching Hospital in Ibadan, Nigeria, out of 1300 patients’ 
clinical samples 346 non-duplicate S. aureus isolates were obtained during the 1-year 
surveillance in 2007. All isolates underwent antibiotic susceptibility testing, toxin gene analysis, 
MLST (multilocus sequence typing), agr group and spa typing. And for MRSA SCCmec typing 
was performed. 20.23% of the 346 isolates were methicillin-resistant. 33 patients’ isolates 
(47.15%) fulfilled the definition criteria for CA-MRSA according to the review of the medical 
charts. The majority of MRSA strains analyzed were isolated from surgical and paediatric 
patients. The commonest types of infection identified with MRSA were surgical site infections 
(>70%) whereas for CA-MRSA were conjunctivitis and otitis in 19 patients (57.6%) and 
accidental skin and subcutaneous tissue infection in 14 patients (42.4 %). The MSSA strains 
(ST1, ST5, ST15, ST7, ST8, ST25, ST30, ST72, ST80, ST121 and ST508) were heterogeneous 
by pheno- and genotypic analysis. The first report and genetic analyses of PVL-positive ST88 
strain (agr III, SCCmec IV) in Nigeria is shown in this study. ST88 was resistant to 
trimethoprim-sulfamethoxazole besides to penicillin and oxacillin. CA-MRSA infections are 
rapidly increasing among young patients with ophthalmologic and auricular infections. Urban 
regions of lower socioeconomic status and evidence of overcrowding appear to be at higher risk 




Staphylococcus aureus is an important pathogen in human infections and is implicated in a wide 
variety of infections (13,19,28). In Nigeria S. aureus constitutes significant epidemiologic and 
therapeutic problems. Nigeria is the highest populated African country and Ibadan is the capital 
of the Southwest province Oyo with a population density of 3.6 million and is the largest in 
geographical area. Over the last 20 years the incidence of both community-acquired (CA) and 
hospital-acquired (HA) S. aureus infections have increased, while antibiotic treatment is 
increasingly hampered by the spread of S. aureus strains, which are resistant to multiple 
antibiotics including methicillin (11,19,32). 
 
The African data on S. aureus, particularly antibiotic susceptibilities, are extremely limited (3, 
27), although methicillin-resistant S. aureus (MRSA) has disseminated in African countries as 
well. Between 1996 and 1997 the prevalence of MRSA was determined in eight African countries 
  
and was relatively high in Nigeria, Kenya, and Cameroon (21 to 30%) and below 10% in Tunisia 
and Algeria, although in Algeria this rate creased to 14% (16,26). All MRSA isolates were 
sensitive to vancomycin. The isolates were also highly sensitive to ciprofloxacin, except in 
Kenya, Morocco, and Tunisia, where relative resistance to this drug has been described (16). 
Moreover, the results of four years' studies from a number of hospitals in Kenya have shown that 
90% of patients admitted in burn units were colonized or infected with MRSA (20). The 
increasing prevalence of MRSA infections in non-hospitalized patients due to the emergence of 
unique community-associated S. aureus strains became also a Nigerian problem as it is global. 
Due to the fact that the genetic analysis of indigenous S. aureus strains is limited in Nigeria we 
aimed to study the genetics, prevalence and dissemination of such strains in Ibadan, one of the 
biggest university hospitals in Nigeria (2,23). 
 
The objectives of this study were (1) to determine antibiotic susceptibility profiles, genotypes and 
toxin profiles of methicillin-susceptible S. aureus and MRSA from two hospitals in Ibadan, 
Nigeria; (2) to determine the prevalence and (3) to characterize the genetic determinants of CA 
MRSA strains on hospital admission. 
 
 
Materials and Methods 
 
Study duration and population 
 
From 2006 to 2007, out of 1300 clinical samples 346 non-duplicate S. aureus isolates identified 
in patients on hospital admission were obtained from two hospitals in Southwestern Nigeria, 
Oluyewo Hospital and University Teaching Hospital, both in Ibadan. 
 
Among the 1300 patients 65% (845) were adults at the departments of surgical units, 20% (260) 
at the department of paediatrics and neonatology, and the remaining 195 patients were at the 
medical department. Most of the isolates (90%) were obtained from the University Teaching 
Hospital and the remaining number of isolates was from the Oluyewo Hospital, both in Ibadan. 
More than 70% of the total number of isolates was recovered from wound samples, 72 (21%) 
from corneal, conjunctival and auricular swabs, 15 (4.3%) from genital swabs, and 16 (4.6%) 
from nasal swabs. 
 
 
Antimicrobial susceptibility testing 
 
The identification and susceptibility testing (penicillin, oxacillin, trimethoprim/sulfamethoxazole, 
tetracycline, erythromycin, clindamycin, ciprofloxacin, moxifloxacin, gentamicin, vancomycin, 
teicoplanin, linezolid, quinupristin/dalfopristin, fosfomycin, fusidic acid, nitrofurantoin, 
orfloxacin, levofloxacin, rifampicin, tobramycin) were performed by the automated VITEK 2®  
system (bioMérieux, Marcy-l'Etoile, France). The results were interpreted in accordance to the 
current Clinical Laboratory Standards Institute (4) guidelines: breakpoints for oxacillin 
susceptibility were used: MICs of 2 mg/l indicated susceptibility and MICs of 4 mg/l indicated 





Chromosomal DNA was isolated from overnight cultures grown on blood agar at 37 °C. 
Genomic DNA was extracted by using the Qiagen®  DNA extraction kit according to the 
manufacturers suggestions (Qiagen, Hilden, Germany) with the modification that 20μl of 
lysostaphin (Sigma; 1mg/ml) and 20μl lysozyme (Qiagen; 100mg/ml) were added at the cell lysis 
step. The concentration of the DNA was assessed by a spectrophotometer (7). 
 
 
agr group-specific multiplex PCR, PVL  gene and toxin gene detection 
Extracted genomic DNA was used as a template to amplify specific agr alleles. For multiplex 
PCR one primer set was prepared to amplify the four specific S. aureus agr alleles using the 
primers as described by Lina et al. (18). Details were given previously (7). 
 
  
Genes for sea-e, seg-h, tsst-1, eta, etb, hlgA, hlgCB, lukE-lukD, lukS-lukF-PV, were detected by 
PCR as described previously (7). We determined the presence of specific staphylococcal virulence 
genes and detected sequences specific for staphylococcal enterotoxin genes (sea-e, seg, seh, sei, 
sej), as 
well as the toxic-shock syndrome toxin gene (tst), PVL genes (lukS-PV–lukF-PV), LukE–lukD 
leukocidin 
genes (lukE–lukD), and hemolysin genes (hlg). The positivity of the genes pvl and tst was confirmed 




PCR for analysis of SCCmec type 
 
SCCmec types were determined by use of a multiplex PCR strategy that generated a specific 
amplification pattern for each SCCmec structural type, according to the method described by 
Oliveira and de Lencastre. The analysis of the SCCmec type was performed according to 
previously described procedures (25). 
 
 
spa gene typing 
 
The polymorphic X region of the protein A gene (spa) was amplified from all S. aureus isolates 
as described previously by Harmsen et al. (12). All sequencing reactions were carried out with an 
ABI Prism BigDye Terminator cycle sequencing ready reaction kit (Applied Biosystems, Foster 
City, CA). The spa type was assigned by using Ridom StaphType software (version 1.4; Ridom 





MLST was performed according to previously published protocols. (5). Briefly, standard DNA 
amplification and sequencing of the seven housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi, 
yqiL) was performed on all S. aureus isolates. Nucleotide sequences were determined for both 
strands using published primers and compared to existing sequences in the MLST database 
(http://www.mlst.net) for assignment of allelic numbers. The isolates were assigned a sequence 
type (ST) number according to their allelic profiles. Clonal complexes were defined as isolates 
that were identical by 5 or more alleles. Phylogenetic relationships among the MSSA and MRSA 
were then assessed by cluster analysis, the unweighted-pair group method using average linkages 
and minimal spanning tree (MST) algorithm of the BioNumerics software applied to the MLST 
sequence data. The sequences for the variable sites from the seven gene fragments were 





Antibiotic resistance of S. aureus isolates 
 
A total of 346 S. aureus isolates were investigated during the study period, out of which 70 were 
methicillin-resistant, giving an MRSA prevalence rate of 20.23% among the entire subject 
population. The youngest patient with MRSA was 2 years old while the oldest was 57 years in 
the study population. The age range for patients with HA-MRSA is 2-57 years whereas the age 
range in the CA-MRSA was 6-20 years. All studied S. aureus isolates were uniformly sensitive to 
vancomycin, teicoplanin, and fusidic acid. We found different resistance phenotypes (Table1) 
using a panel of antibiotics (penicillin [PEN], oxacillin [OXA], trimethoprim/sulfamethoxazole 
[SXT], tetracyline [TET], erythromycin [ERY], clindamycin [CLI], gentamycin [GEN], 
vancomycin [VAN], teicoplanin [TEI], linezolid [LIN], fusidic acid [FUS], ciprofloxacin [CIP], 
rifampicin [RIF]). 
 
The overall susceptibility patterns of the CA-MRSA to the following antibiotics were as follows: 
9.5% for SXT, 66.7% for TET, GEN, CIP and ERY, and 100% for FUS, LIN, RIF, TEI and 
VAN. The higher prevalence of resistance to trimethoprim-sulfamethoxazole in this environment 
  





MLST and relatedness of the clonal clusters 
 
Among the 14 identified STs ST88 (n=32), ST241 (n=7) and ST250 (n=30) were representatives 
for MRSA strains. A minimum spanning tree was constructed by applying the software 
Bionumerics. Figure 1 depicts the clustering of the STs detected in Nigeria together with 
representatives of the international S. aureus clones which indicate the relatedness between 
MSSA in this study and MRSA pandemic clones (Fig. 1). The sequence types ST8-MSSA, 




MSSA and MRSA strains and clinical significance 
 
Among the MRSA strains ST88-MRSA-IV – as community-associated clone - was detected in 
outpatients from the University Hospital (n=26) and Oluyewo Hospital (n=7) in Ibadan with 
respective diseases and no healthcare history in previous 1.5 years. These were detected within 
within 48 hours of admission to the hospital without permanent indwelling catheter and 
percutaneous medical device (e.g. tracheostomy tube and other catheter) within one year of 
MRSA detection. Additional criteria were no known positive culture for MRSA and no history of 
hospitalization, surgery, dialysis, or long-term care facility. The patients were presented 
predominantly conjunctivitis, cataract, otitis, pyomyositis and posttraumatic wound infections, 
whereas ST241-MRSA strains were common in hospitalized burn patients. ST250-MRSA and 
ST508-MSSA isolates were detected in diabetic patients and those with urinary tract infection 
(UTI). ST88-MSSA was mostly associated with cellulitis and postsurgical infections whereas 
ST30-MSSA isolates were obtained from different diagnosed patients with traumatic head injury, 
osteomyelitis, cataract, postsurgical wound infections and accidental skin infections. ST5-, ST7- 
and ST8-MSSA strains were isolated from patients with diabetic foot, UTI, gun-shot injury, 
multiple fractures, postsurgical wounds and polytraumatized patients. 
 
 
Toxin gene detection and agr groups 
 
None of the S. aureus isolates were positive for the toxin genes sed, see, and seh. Furthermore, 
none of the MRSA isolates were positive for sea gene whereas 32 out of 276 MSSA isolates were 
sea positive. 44 out 276 MSSA isolates (ST1, ST121, ST15, ST25, ST30, ST5) were positive for 
seb and 6 MRSA isolates (ST250) were positive for seb. All the MSSA isolates which were typed 
as ST508 (n=9) and few others (ST5 (n=2), ST5 (n=2), ST7 (n=2)) were positive for sec whereas 
none of the MRSA isolates expressed this toxin gene. MSSA isolates from skin lesions or eye 
and wound infections were more likely to produce toxins (81% and 68% respectively) than nasal 
isolates (11%). Those belonging to agr III were preferentially positive for pvl expression, 
especially the CA-MRSA ST88 (n=33), besides the MSSA ST30 (n=30). PVL positive were also 
the MSSA isolates typed as ST1 (n=22 out of 22), ST121 (n=21 out of 38), and ST80 (n= 8 out of 
8). Forty-two (52.85%) of the 70 MRSA isolates were hospital-acquired (HA). And the 33 
patients’ isolates (47.15%) were acquired in the community (CA) (see Table 1 for details on 
toxoin gene expression) and these patients fulfilled the definition of having CA-MRSA according 
to the review of the medical charts. The majority of MRSA strains analyzed were isolated from 
surgical and paediatric patients. The commonest types of infection identified with MRSA isolates 
during the period of study were surgical site infections (>70%) whereas for CA-MRSA were 
conjunctivitis and otitis in 19 patients (57.6%) and accidental skin and subcutaneous tissue 
infection in 14 patients (42.4 %). The expression of the tst gene was detected in 8 of the 70 
MRSA isolates (five ST250, two ST88 and one ST8) and in 54 of the 276 MSSA isolates (all 
ST1 and ST508, four ST30 and eight ST5). 
 
 
SCCmec typing of MRSA isolates 
 
The sequence types MRSA-ST88 (n=33) and MRSA-ST241 (n=7) were grouped in SCCmec type 
  






Knowledge of epidemiology of bacterial infections is very important for appropriate decision 
making in the treatment of infections, such as septicaemia, wound and postsurgical infections. 
Iroha et al. (15) investigated in Lagos conjunctivitis cases of neonates in a prospective study. The 
incidence of conjuctivitis in the newborn was 18 per 1000 live births. S. aureus (37.4%) was the 
most predominant aetiologic pathogens among the other bacteria (coagulase negative 
staphylococci (12.3%), Klebsiella pneumoniae (12.9%) and Pseudomonas aeruginosa (8.2%). 
The incidence of S. aureus-caused eye infection is consistent with our study, in particular in out 
patients with CA-MRSA-positive conjunctivitis. This might be an indication that antibiotics are 
now more extensively used in the community besides hospital-settings, especially broad 
spectrum antibiotics. S. aureus (61.2%) was the dominant cause of septicaemia and mortality in 
neonates according to Udo et al. (30). Another study investigated the bacteriology of non 
surgical wound infections in Ibadan. S. aureus (38%) was the predominant pathogen followed by 
the Gram-negative bacteria (each 7-19%). High rates of antibiotic resistance were recorded 
among these isolates (24). Thanni et al. (29) determined the prevalence of bacterial pathogens in 
wounds from various units of a Nigerian tertiary hospital orthopedics and traumatology 
department. In this retrospective study from 1995 to 2001 Pseudomonas aeroginosa was the most 
common pathogen among the inpatients whereas S. aureus was more common among 
outpatients. The rate of isolation of Gram-positive bacteria in general decreased while that of S. 
aureus in particular increased as stated by Thanni et al. (29). 
 
The MRSA prevalence in our study was moderate (20.23%) as compared to previous studies in 
Southwestern Nigeria, which ranged from 1.4% to 50% (1-3, 16, 23, 27). However, it should be 
considered that the detection of the mecA gene, which is the “gold standard” for determining 
methicillin resistance, was not investigated in some of these previous studies. A recent 
multicenter study in Southwestern Nigeria confirmed resistance to methicillin by the detection of 
the mecA gene by PCR and reported a lower prevalence rate of 1.4% (1). Despite the low MRSA 
rate in our study, it is evident that multi-resistant MSSA occurred frequently in Southwestern 
Nigeria (Table 1). However, the MRSA isolates were predominantly associated with infections 
(87%) as elsewhere observed (27). Nevertheless, the prevalence of community associated MRSA 
(47%) was higher in our study as compared to that (29%) of Taiwo et al. (27) The prevalence of 
MRSA among the S. aureus isolates at the University College Hospital, Ibadan, Nigeria in 1999 
was generally set at 27% which was higher than 1972 value of 1%. Forty-one percent of the 
MRSA isolates were from inpatients while 59% were from outpatients. The high incidence of 
MRSA in outpatients was unusual at that time (23). A survey of MRSA at a teaching hospital in 
Ilorin, Nigeria suggested a similar MRSA prevalence rate at 34.7% (27). Many African countries 
have an extraordinary tradition of herbal or traditional medicine (21). Thus, the low cost and high 
acceptance and ease of access to such traditional ‘therapies’ make them the most common form 
of African alternative medicine. Therefore, the antibiotics in the community do not play the 
major role and hence the resistance problem is rather low for oxacillin or methicillin. In the 
hospital environment, the acquisition of the SCCmec (in its various forms) by multi-resistant 
MSSA could make infection control measures extremely difficult and could have serious 
consequences. The resistances to sulfonamides and tetracycline were remarkable in MRSA 
clones and sulfonamides were recommended and administered to treat MRSA infections in 
Nigeria (27). Hence, these antibacterial agents should not be considered anymore as first-line 
drugs for treatment of MRSA infections in Nigeria. 
 
MLST of S. aureus strains in Nigeria indicated that certain major clones of MSSA are extremely 
successful in Nigeria (1). They include ST25, ST30, and ST120/121 which have been recognized 
as internationally well-disseminated clones (6) along with the ST8 MSSA clone, which appeared 
to possess some epidemic potentials and had acquired the mecA gene (1). These STs were also 
detected in our study. MSSA isolates are often more genetically variable and have commonly 
been the subject of more general surveillance studies, but relatively few studies with molecular 
typing. Goering et al. (8) reported ST121 as the most common PVL-positive MSSA clone 
(pulsed-field type USA1200), which was found primarily in South Africa and the Russian 
Federation. In our study ST121 clone was also prevalent and was positive luk-PV gene. Another 
  
MSSA clone in our study belonging to the clonal complex CC1 was ST1 which was detected in 
predominantly PVL-negative isolates originating in India, South Africa, the United States, and 
Germany, with the difference that the Nigerian clone expressed luk-PV and tst genes. The MSSA 
clone ST5 (CC5) and ST30 (CC30) were identified South Africa, the United States, and Germany 
as well according to Goering et al. (8). In comparison to our study isolates Adesida et al. (2) 
identified in their MSSA isolates from Lagos different lineages. Among their 17 MSSA isolates 
the spa typing revealed nine different types with predominance of spa t007 and t454. Considering 
the global and dynamic nature of MRSA in HA and CA infections, continued surveillance is 
important for clearer understanding of the epidemiology of these organisms. 
To date, most SCCmec IV CA-MRSA isolates have had MLST allelic profiles that are not found 
 in studies of HA-MRSA. However, CA-MRSA has the potential to move into the hospital setting 
and cause outbreaks. This study reiterates that the detection of SSCmec type IV CA-MRSA was 
associated with the PVL production. 
 
In contrast to the MRSA strains in Algeria (26) our MRSA isolates were not resistant to 
gentamicin. In the Algerian study the treatment options in the case of multiple-antibiotic-resistant 
MRSA strains included cotrimoxazole (SXT) for minor infections and glycopeptides for severe 
infections whereas SXT is not recommended for the Nigerian MRSA strains in Ibadan anymore 
as the resistance rate to SXT is approx. 53%, nearly all ST88-MRSA isolates and ST241-MRSA 
isolates, but none of the ST250-MRSA isolates were SXT resistant. Grim et al. (9) stated that 
clonal outbreaks of MRSA resistant to SXT have been described; of these, the Brazilian clone has 
more often been resistant to SXT than the Iberian clone. Rates of SXT resistance were 
particularly high in institutions serving large numbers of patients infected by the human 
immunodeficiency virus, due to increased exposure for Pneumocystis prophylaxis. 
 
Vandenesch et al. (31) described continent-specific PVL-positive CA-MRSA clones - mainly on 
an agr group 3 background - and characterized them by their sequence type (ST). The main 
European CA-MRSA clone, ST80, was detected in France, Switzerland, the Netherlands, 
England, Belgium, and Germany, but also in northern Europe (e.g. Denmark), where MRSA 
strains are rare in hospitals. ST80-MRSA clone is usually resistant to tetracycline (mediated by 
the tetK gene), intermediate to fusidic acid (far1 gene), and resistant to kanamycin (aph3´-III 
gene). We observed the prevalence of ST80-MSSA isolates in Nigeria which were tetracycline 
resistant as well, but susceptible towards fusidic acid. One of the most prevalent PVL-positive 
CA-MRSA clones in the United States (USA300) belongs to ST8; other US clones include 
USA400 (ST1), USA1000 (ST59), and USA1100 (ST30). ST30 is also a major clone in Asia and 
Oceania and is referred to as the South West Pacific MRSA clone. This sequence type was 
prevalent in Nigeria as a MSSA strain. In Singapore, as an international travel hub, several clones 
belonging to ST80, ST30, and ST59 have been reported. The prevalence of PVL-positive CA 
MRSA varies considerably from continent to continent. In the United States, MRSA were 
isolated from 50% of patients with skin and soft-tissue infections seen in emergency departments 
of 11 cities (97% of isolates belonged to clone USA300). In Europe, the prevalence of CA 
MRSA is lower, at ≈1–3% and in Africa this needs more investigational study. 
In our study the MRSA strains were less “toxigenic” as compared to the MSSA strains (ST5, ST7 
and ST30) which were more positive for PVL and tst. In contrast to our finding the MRSA 
isolates in a Japanese study evaluated that both MRSA and MSSA isolates carried a number of 
superantigenic toxin genes, but the MRSA isolates harboured more superantigenic toxin genes 
than the MSSA isolates (14). Hu et al. (14) compared the prevalence of superantigenic toxin 
genes in MRSA and MSSA and concluded that some of their MRSA isolates were sec, seg and tst 
positive. In our study none of the MRSA isolates shared these genes together, only one MSSA 
isolate typed ST508 was positive for sec, seg and tst together. This notable higher prevalence in 
Japanese MRSA isolates indicated that possession of the sec and tst genes in particular appeared 
to be a habitual feature of MRSA (14), unlike to the Nigerian MRSA. 
 
This study provides a comprehensive overview on the molecular epidemiology and genetic 
diversity of S. aureus at the largest university clinic in Nigeria. First, it shows high prevalence of 
PVL-positive MSSA. Second, high heterogeneity of MSSA with broader resistance profiles was 
seen as compared to the MRSA strains (ST250 and ST88) which are homogenous. ST88 was 
resistant to trimethoprim-sulfamethoxazole besides to penicillin and oxacillin whereas ST250 as 
hospital MRSA was additionally resistant to tetracycline, ciprofloxacin and gentamycin (Table 
1). Trimethoprim-sulfamethoxazole and tetracycline are listed among antibacterial agents that 
have been rendered ineffective or for which there are serious concerns regarding bacterial 
resistance in Nigeria (22). Therefore, the formulation and implementation of a national drug 
  
policy by governments are fundamental to ensure rational drug use. Control of community 
acquired S. aureus will still remain a challenge for some regions in Nigeria, since the 
transmission is linked to migration and touristic reasons. 
 
Two types of SCCmec were found with CC8 complex, the ST241-MRSA-IV strain and ST250- 
MRSA-I (Fig. 1). ST250-MSSA is most probably putative ancestor of ST250-MRSA by the 
insertion of the SCCmec I. ST250-MSSA itself might have derived from putative ST8-MSSA 
ancestor, common to all strains belonging to CC8 (14). 
In our present study we showed that in most of the clinical departments the less toxigenic MRSA 
strains circulate together with the more toxigenic MSSAs, e.g. ST30 and ST1. This might be 
benefiting for the toxin gene transfer which could occur among the methicillin-susceptible and - 
resistant strains (17). 
In conclusion, the application of the different typing methods to our Nigerian strains provided 
important information on their clonal relationship and might also strengthen the representation of 
the population of S. aureus circulating in Nigeria. Moreover, this study summarizes 
comprehensive epidemiologic data and use of other genetic marker to investigate outbreak 
situations in such healthcare setting. 
To the best of our knowledge, this is the first report of detection and genetic characterization of 
ST88 strain in Nigeria. ST88 was also isolated in Asia (11) with the significant difference that the 
Nigerian clone expresses PVL and is sensitive to tetracycline and fusidic acid, in contrast to the 
European CA-MRSA clones (32). Therefore, epidemiological studies on the clonal relationship 
of MRSA strains in Nigeria with worldwide clones would be useful and important in 
understanding the global dissemination of such clones. 
 
Limitations to our study include the limited number of patients. Thus, the prevalence of the 
MRSA in general and CA-MRSA might be underestimated. Future prospective studies may 
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Antibiotic resistance patterns and genotypic analysis (MLST, spa types) of the Staphylococcus 





a the major frequent antibiotic resistance patterns are given for each sequence type [PEN, penicillin; OXA, oxacillin; 
SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; CIP, ciprofloxacin; ERY, erythromycin; GEN, gentamycin; 




















Minimum spanning tree based on MLST indicates the estimated relationships of the 14 STs based 
on sequence alignments and analysis of the ST allelic profiles, including representatives of the 
clonal complexes (CC). ST88, ST241 and ST250 represent MRSA. Each ST is represented by a 
circle and the size of circle is proportional to the isolate size belonging to the respective ST. 
Relationships between the strains were depicted as connections between isolates and the lengths 
of the branches linking them (MRSA are black- and MSSA grey-colored). 
 
 
 
  
